Annual EBIT
$12.58 M
-$9.71 M-43.56%
31 December 2023
Summary:
Organogenesis Holdings annual earnings before interest & taxes is currently $12.58 million, with the most recent change of -$9.71 million (-43.56%) on 31 December 2023. During the last 3 years, it has fallen by -$16.46 million (-56.68%). ORGO annual EBIT is now -82.11% below its all-time high of $87.00 million.ORGO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$6.29 M
+$20.21 M+145.22%
30 September 2024
Summary:
Organogenesis Holdings quarterly earnings before interest & taxes is currently $6.29 million, with the most recent change of +$20.21 million (+145.22%) on 30 September 2024. Over the past year, it has dropped by -$1.79 million (-22.11%). ORGO quarterly EBIT is now -73.55% below its all-time high of $23.80 million, reached on 30 September 2020.ORGO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$12.75 M
-$1.79 M-16.30%
30 September 2024
Summary:
Organogenesis Holdings TTM earnings before interest & taxes is currently -$12.75 million, with the most recent change of -$1.79 million (-16.30%) on 30 September 2024. Over the past year, it has dropped by -$35.35 million (-156.41%). ORGO TTM EBIT is now -115.62% below its all-time high of $81.61 million, reached on 30 June 2021.ORGO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGO EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.6% | -22.1% | -156.4% |
| 3 y3 years | -56.7% | -56.2% | -117.7% |
| 5 y5 years | +123.3% | +176.1% | +64.7% |
ORGO EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -82.1% | at low | -68.1% | +145.2% | -117.7% | at low |
| 5 y | 5 years | -82.1% | +123.3% | -73.5% | +145.2% | -115.6% | +64.7% |
| alltime | all time | -82.1% | +123.3% | -73.5% | +131.4% | -115.6% | +76.4% |
Organogenesis Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.29 M(-145.2%) | -$12.75 M(+16.3%) |
| June 2024 | - | -$13.92 M(+263.5%) | -$10.96 M(-186.1%) |
| Mar 2024 | - | -$3.83 M(+195.9%) | $12.73 M(+1.2%) |
| Dec 2023 | $12.58 M(-43.6%) | -$1.29 M(-116.0%) | $12.58 M(-44.3%) |
| Sept 2023 | - | $8.08 M(-17.3%) | $22.60 M(+38.6%) |
| June 2023 | - | $9.77 M(-345.7%) | $16.30 M(-11.6%) |
| Mar 2023 | - | -$3.98 M(-145.6%) | $18.44 M(-17.3%) |
| Dec 2022 | $22.29 M(-68.3%) | $8.72 M(+389.0%) | $22.29 M(-33.1%) |
| Sept 2022 | - | $1.78 M(-85.0%) | $33.31 M(-27.4%) |
| June 2022 | - | $11.91 M(-9194.7%) | $45.89 M(-20.3%) |
| Mar 2022 | - | -$131.00 K(-100.7%) | $57.58 M(-18.1%) |
| Dec 2021 | $70.32 M(+142.1%) | $19.74 M(+37.5%) | $70.32 M(-2.6%) |
| Sept 2021 | - | $14.36 M(-39.2%) | $72.18 M(-11.6%) |
| June 2021 | - | $23.61 M(+87.1%) | $81.61 M(+46.3%) |
| Mar 2021 | - | $12.61 M(-41.6%) | $55.78 M(+89.7%) |
| Dec 2020 | $29.04 M | $21.60 M(-9.2%) | $29.40 M(+277.2%) |
| Sept 2020 | - | $23.80 M(-1168.5%) | $7.79 M(-132.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$2.23 M(-83.8%) | -$24.27 M(-17.7%) |
| Mar 2020 | - | -$13.77 M(>+9900.0%) | -$29.48 M(-0.3%) |
| Dec 2019 | -$29.56 M(-45.2%) | -$7000.00(-99.9%) | -$29.56 M(-18.2%) |
| Sept 2019 | - | -$8.27 M(+11.1%) | -$36.15 M(-4.9%) |
| June 2019 | - | -$7.44 M(-46.3%) | -$38.00 M(-20.4%) |
| Mar 2019 | - | -$13.85 M(+110.0%) | -$47.76 M(-11.5%) |
| Dec 2018 | -$53.96 M(+725.0%) | -$6.59 M(-34.8%) | -$53.94 M(+6.6%) |
| Sept 2018 | - | -$10.11 M(-41.2%) | -$50.59 M(+16.7%) |
| June 2018 | - | -$17.20 M(-14.1%) | -$43.33 M(+64.4%) |
| Mar 2018 | - | -$20.03 M(+517.0%) | -$26.35 M(+302.9%) |
| Dec 2017 | -$6.54 M(-27.9%) | -$3.25 M(+13.8%) | -$6.54 M(-47.0%) |
| Sept 2017 | - | -$2.85 M(+1186.3%) | -$12.34 M(+29.9%) |
| June 2017 | - | -$221.80 K(+1.5%) | -$9.50 M(+2.4%) |
| Mar 2017 | - | -$218.60 K(-97.6%) | -$9.28 M(+2.2%) |
| Dec 2016 | -$9.07 M | -$9.04 M(>+9900.0%) | -$9.07 M(>+9900.0%) |
| Sept 2016 | - | -$14.50 K(+2800.0%) | -$30.50 K(+90.6%) |
| June 2016 | - | -$500.00(-96.8%) | -$16.00 K(+3.2%) |
| Mar 2016 | - | -$15.50 K | -$15.50 K |
FAQ
- What is Organogenesis Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Organogenesis Holdings?
- What is Organogenesis Holdings annual EBIT year-on-year change?
- What is Organogenesis Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly EBIT year-on-year change?
- What is Organogenesis Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Organogenesis Holdings?
- What is Organogenesis Holdings TTM EBIT year-on-year change?
What is Organogenesis Holdings annual earnings before interest & taxes?
The current annual EBIT of ORGO is $12.58 M
What is the all time high annual EBIT for Organogenesis Holdings?
Organogenesis Holdings all-time high annual earnings before interest & taxes is $87.00 M
What is Organogenesis Holdings annual EBIT year-on-year change?
Over the past year, ORGO annual earnings before interest & taxes has changed by -$9.71 M (-43.56%)
What is Organogenesis Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of ORGO is $6.29 M
What is the all time high quarterly EBIT for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly earnings before interest & taxes is $23.80 M
What is Organogenesis Holdings quarterly EBIT year-on-year change?
Over the past year, ORGO quarterly earnings before interest & taxes has changed by -$1.79 M (-22.11%)
What is Organogenesis Holdings TTM earnings before interest & taxes?
The current TTM EBIT of ORGO is -$12.75 M
What is the all time high TTM EBIT for Organogenesis Holdings?
Organogenesis Holdings all-time high TTM earnings before interest & taxes is $81.61 M
What is Organogenesis Holdings TTM EBIT year-on-year change?
Over the past year, ORGO TTM earnings before interest & taxes has changed by -$35.35 M (-156.41%)